Chemistry, genetics and computing give us clues to understand cancer cells.
Sometimes a drug hits cancer hard. Sometimes the cancer cells are unfazed. But it's often hard to know which outcome to expect.
A group of scientists at the National Cancer Institute has spent the last three years turning some mathematical algorithms loose on giant sets of data to better understand the relationship between cancerous cells and cancer drugs.
For the past three years, StoryCorps' Legacy program has given people facing serious illness the chance to record interviews with loved ones and caregivers. Recently, StoryCorps expanded the program to include children.
In 2007, Faith Marr was diagnosed with a rare bone cancer on her spine. She was 4 years old. That year she had her first of eight surgeries, replacing her vertebrae with titanium rods. Doctors were uncertain about her chances of survival.
A billboard advertising robotic surgery hangs outside Boston's Fenway Park in 2009. Hospitals and doctors have heavily promoted robotic surgery.
Credit Charles Krupa / AP
Pretty much every medical organization has told men to back off on screening for prostate cancer, because it can lead to unneeded treatment, including surgery that can leave a man incontinent and impotent.
Sometimes, it doesn't take a major diet overhaul to get significant health benefits. Small changes can be helpful, too.
This seems to be the take-home message from a new study in JAMA Internal Medicine linking olive oil and nuts to improved survival from prostate cancer.
Researchers studied the fat intake of more than 4,500 men who had been diagnosed with non-metastatic prostate cancer (this is cancer that's still confined to the prostate gland and has not spread to another place in the body).